3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Phase 2
2
Status
Completed
14
Recruiting
7
Terminated
5
Active not recruiting
5
Unknown
4
Withdrawn
2
Not yet recruiting
2
Enrolling by invitation
1
Sponsor Class
OTHER
4
Study Type
Interventional
4
Sponsor
Cancer Type
Breast
4
Conditions
Breast Neoplasms
37
Advanced Breast Cancer
5
Neoplasm Metastasis
4
Neoplasms
2
The Neoadjuvant Therapy
1
Solid Tumor, Adult
1
Recurrent Uterine Corpus Carcinoma
1
Hormone Receptor-positive Advanced Breast Cancer
1
Hormone Receptor Positive Advanced Breast Cancer
1
HR-positive, HER2-negative and PIK3CA Mutation Advanced Breast Cancer
1
HR Positive/HER-2 Negative Breast Cancer
1
Estrogen Receptor-positive Breast Cancer
1
Carcinoma, Intraductal, Noninfiltrating
1
Carcinoma, Ductal, Breast
1
Breast Neoplasm Female
1
Breast Diseases
1
Breast Carcinoma In Situ
1
Breast Cancer Organoids
1
Brain Neoplasms
1
Interventions
Fluorouracil
18
Oxaliplatin
17
Capecitabine
16
Leucovorin
13
Cisplatin
12
Gemcitabine
11
Drug Therapy
11
Irinotecan
10
Radiosurgery
9
Cetuximab
9
Bevacizumab
9
pembrolizumab
8
Docetaxel
8
Everolimus
7
spartalizumab
6
Sunitinib
6
Radiotherapy
6
Paclitaxel
6
Neoadjuvant Therapy
6
Cyclophosphamide
6
Trastuzumab
5
S 1 (combination)
5
Nivolumab
5
Immunotherapy
5
Immune Checkpoint Inhibitors
5
Chemotherapy, Adjuvant
5
Carboplatin
5
palbociclib
4
manganese chloride
4
Surgical Procedures, Operative
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
4 trials
Recent
Start date
Enrollment
Unknown
×
Neoplasm Metastasis
×
Fulvestrant
×
Clear all
NCT02690480
2020-02-05
FLIPPER
Spanish Breast Cancer Research Group
Phase 2
Unknown
189 enrolled
NCT03560856
2018-06-18
PALPETBIO
Assistance Publique - Hôpitaux de Paris
Phase 2
Unknown
54 enrolled
NCT02383030
2016-06-15
FUMANCE
Consorzio Oncotech
Phase 3
Unknown
156 enrolled
NCT02404051
2016-06-15
FEVEX
Consorzio Oncotech
Phase 3
Unknown
745 enrolled